244 related articles for article (PubMed ID: 29293984)
1. Complications during neoadjuvant therapy and prognosis following surgery for esophageal cancer.
Markar SR; Johar A; Maisey N; Lagergren P; Lagergren J
Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29293984
[TBL] [Abstract][Full Text] [Related]
2. University hospital status and prognosis following surgery for esophageal cancer.
Markar SR; Wahlin K; Lagergren P; Lagergren J
Eur J Surg Oncol; 2016 Aug; 42(8):1191-5. PubMed ID: 27288216
[TBL] [Abstract][Full Text] [Related]
3. Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study.
Rutegård M; Lagergren P; Rouvelas I; Mason R; Lagergren J
Eur J Surg Oncol; 2012 Jul; 38(7):555-61. PubMed ID: 22483704
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
[TBL] [Abstract][Full Text] [Related]
5. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
6. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
7. Time shift in early postoperative mortality after oesophagectomy for cancer.
Rutegård M; Lagergren P; Johar A; Lagergren J
Ann Surg Oncol; 2015 Sep; 22(9):3144-9. PubMed ID: 25649859
[TBL] [Abstract][Full Text] [Related]
8. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.
Reisinger KW; Bosmans JW; Uittenbogaart M; Alsoumali A; Poeze M; Sosef MN; Derikx JP
Ann Surg Oncol; 2015 Dec; 22(13):4445-52. PubMed ID: 25893413
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
10. Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study.
Rouvelas I; Zeng W; Lindblad M; Viklund P; Ye W; Lagergren J
World J Surg; 2006 Dec; 30(12):2182-90; discussion 2191-2. PubMed ID: 17006610
[TBL] [Abstract][Full Text] [Related]
11. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.
van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL;
Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163
[TBL] [Abstract][Full Text] [Related]
12. University hospital status and surgeon volume and risk of reoperation following surgery for esophageal cancer.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Eur J Surg Oncol; 2018 May; 44(5):632-637. PubMed ID: 29548804
[TBL] [Abstract][Full Text] [Related]
13. Weekday of Esophageal Cancer Surgery and Its Relation to Prognosis.
Lagergren J; Mattsson F; Lagergren P
Ann Surg; 2016 Jun; 263(6):1133-7. PubMed ID: 26565140
[TBL] [Abstract][Full Text] [Related]
14. Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
Markar SR; Mackenzie H; Lagergren P; Lagergren J
Ann Surg; 2018 Jul; 268(1):100-105. PubMed ID: 28394868
[TBL] [Abstract][Full Text] [Related]
15. The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer.
Kano K; Aoyama T; Yoshikawa T; Maezawa Y; Nakajima T; Hayashi T; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Cho H; Ogata T
Ann Surg Oncol; 2018 Jul; 25(7):2034-2043. PubMed ID: 29748890
[TBL] [Abstract][Full Text] [Related]
16. Extent of lymph node removal during esophageal cancer surgery and survival.
van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
[TBL] [Abstract][Full Text] [Related]
17. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
[TBL] [Abstract][Full Text] [Related]
18. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of cytokine expression during neoadjuvant chemoradiotherapy and subsequent surgery in esophageal cancer patients.
Bosch DJ; Wang D; Nijsten MW; Mul VE; Hospers GA; Burgerhof JG; Struys MM; Plukker JT
Am J Surg; 2016 Jul; 212(1):89-95. PubMed ID: 27036621
[TBL] [Abstract][Full Text] [Related]
20. Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study.
Derogar M; Sadr-Azodi O; Johar A; Lagergren P; Lagergren J
J Clin Oncol; 2013 Feb; 31(5):551-7. PubMed ID: 23295792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]